Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.42 |
| ▸ | TP53 | P04637 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.31 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene Glycol SCHEMBL5954224 | 1.00 | TSHR (0.52) | TSHRALDH1A1MAPK1SMN1; SMN2TDP1 | |
| Ethylene Glycol SCHEMBL8916084 | 1.00 | TSHR (0.52) | TSHRALDH1A1MAPK1SMN1; SMN2TDP1 | |
| Ethylene Glycol SCHEMBL5954245 | 1.00 | TSHR (0.52) | TSHRALDH1A1MAPK1SMN1; SMN2TDP1 | |
| Ethylene Glycol SCHEMBL8621973 | 1.00 | TSHR (0.52) | TSHRALDH1A1MAPK1SMN1; SMN2TDP1 | |
| Ethylene Glycol SCHEMBL262676 | 1.00 | TSHR (0.52) | TSHRALDH1A1MAPK1SMN1; SMN2TDP1 | |
| Ethylene Glycol SCHEMBL1005360 | 1.00 | TSHR (0.52) | TSHRALDH1A1MAPK1SMN1; SMN2TDP1 | |
| Ethylene Glycol SCHEMBL5953583 | 1.00 | TSHR (0.52) | TSHRALDH1A1MAPK1SMN1; SMN2TDP1 | |
| Ethylene Glycol SCHEMBL13583287 | 1.00 | TSHR (0.52) | TSHRALDH1A1MAPK1SMN1; SMN2TDP1 | |
| Ethylene Glycol SCHEMBL21932617 | 1.00 | TSHR (0.52) | TSHRALDH1A1MAPK1SMN1; SMN2TDP1 | |
| Ethylene Glycol SCHEMBL5448533 | 0.95 | TSHR (0.56) | TSHRALDH1A1MAPK1SMN1; SMN2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3617256-B1 | SALT TOLERANT POROUS MEDIUM | PALL CORP (US) | 2022-01-19 | — | — | EP | claimed |
| EP-3004268-B1 | ACRYLATED OR METHACRYLATED URETHANE OLIGOMER WITHOUT ISOCYANATE | ARKEMA FRANCE (FR) | 2017-04-12 | — | — | EP | claimed |
| EP-3004268-A1 | ACRYLATED OR METHACRYLATED URETHANE OLIGOMER WITHOUT ISOCYANATE | Arkema France (FR) | 2016-04-13 | — | — | EP | claimed |
| WO-2012131265-A1 | COMPOSITE MATERIAL CONTAINING CARBON NANOTUBES AND PARTICLES HAVING A CORE-SHELL STRUCTURE | ARKEMA FRANCE (FR) | 2012-10-04 | — | — | WO | claimed |
| EP-1924608-B1 | FUNCTIONALIZED POLYMERS AND IMPROVED TIRES THEREFROM | BRIDGESTONE CORP (JP) | 2010-01-27 | — | — | EP | claimed |
| EP-1124862-B1 | PREPARATION OF WATER-SOLUBLE CROSS-LINKED CATIONIC POLYMERS | CIBA SPEC CHEM WATER TREAT LTD (GB) | 2004-10-13 | — | — | EP | claimed |
| EP-3207078-B1 | NON-ISOCYANATE URETHANE MONO- OR MULTIACRYLATE OLIGOMERS | ARKEMA FRANCE (FR) | 2021-10-13 | — | — | EP | disclosed |
| EP-3207078-A1 | MONOFUNCTIONAL OR MULTIFUNCTIONAL URETHANE ACRYLATE OLIGOMERS WITHOUT ISOCYANATE | Arkema France (FR) | 2017-08-23 | — | — | EP | disclosed |
| EP-3004268-B1 | ACRYLATED OR METHACRYLATED URETHANE OLIGOMER WITHOUT ISOCYANATE | ARKEMA FRANCE (FR) | 2017-04-12 | — | — | EP | disclosed |
| WO-2016059340-A1 | MONOFUNCTIONAL OR MULTIFUNCTIONAL URETHANE ACRYLATE OLIGOMERS WITHOUT ISOCYANATE | ARKEMA FRANCE (FR) | 2016-04-21 | — | — | WO | disclosed |
| EP-3004268-A1 | ACRYLATED OR METHACRYLATED URETHANE OLIGOMER WITHOUT ISOCYANATE | Arkema France (FR) | 2016-04-13 | — | — | EP | disclosed |
| WO-2012131265-A1 | COMPOSITE MATERIAL CONTAINING CARBON NANOTUBES AND PARTICLES HAVING A CORE-SHELL STRUCTURE | ARKEMA FRANCE (FR) | 2012-10-04 | — | — | WO | disclosed |
| US-20060264601-A1 | Method for production of alkylene oxide based polymer | NIPPON SHOKUBAI CO., LTD. (JP) | 2006-11-23 | — | — | US | disclosed |